Statistics for Peroxisome proliferator-activated receptor gamma agonists for the prevention of adverse events following percutaneous coronary revascularization-results of the PPAR study
Total visits
| views | |
|---|---|
| Peroxisome proliferator-activated receptor gamma agonists for the prevention of adverse events following percutaneous coronary revascularization-results of the PPAR study | 754 |
Total visits per month
| views | |
|---|---|
| March 2023 | 0 |
| April 2023 | 0 |
| May 2023 | 0 |
| June 2023 | 0 |
| July 2023 | 0 |
| August 2023 | 0 |
| September 2023 | 0 |
Top country views
| views | |
|---|---|
| United States | 415 |
| Australia | 57 |
| China | 49 |
| France | 30 |
| European Union | 26 |
| Germany | 10 |
| Russia | 8 |
| United Kingdom | 6 |
| Netherlands | 5 |
| Ukraine | 4 |
| Italy | 3 |
| India | 2 |
| Japan | 2 |
| Brazil | 1 |
| South Korea | 1 |
Top city views
| views | |
|---|---|
| Mountain View | 71 |
| Woodbridge | 55 |
| Canberra | 53 |
| Sunnyvale | 47 |
| Seattle | 34 |
| Redwood City | 26 |
| South El Monte | 22 |
| Santa Clara | 17 |
| Needham Heights | 12 |
| Columbus | 10 |
| Florence | 7 |
| Kiez | 6 |
| Flinders | 4 |
| Indianapolis | 4 |
| Munich | 4 |
| Groningen | 3 |
| Redmond | 3 |
| San Francisco | 3 |
| Jacksonville | 2 |
| Kissimmee | 2 |
| New York | 2 |
| Oklahoma City | 2 |
| Oxnard | 2 |
| Sayreville | 2 |
| Shenzhen | 2 |
| Absecon | 1 |
| Daejeon | 1 |
| Dallas | 1 |
| Saint Louis | 1 |
| San Antonio | 1 |